2月19日, 南向资金增持中国生物制药4972.50万股,连续5日增持。截止当日收盘,港股通共持有中国生物制药231176.64万股,占流通股12.29%。港股通增持金额前五个股分别为阿里巴巴-W、中国移动、阿里健康、中芯国际、迈富时。中国生物制药近5个交易日上涨9.21%,港股通累计增持13590.11万股;近20个交易日上涨14.09%,港股通累计增持10830.32万股。|2月19日港股通(...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.